How Much?! AbbVie (ABBV) Raises Niaspan Price Despite Study Failures
5/24/2013
More...
|
MEDA: Dymista Reimbursed in Sweden
5/23/2013
More...
|
Duchesnay USA Release: Diclegis® Now Available Nationwide to Treat Pregnant Women With Nausea and Vomiting of Pregnancy (NVP)
5/21/2013
More...
|
Avion Pharmaceuticals, Launches Prenate Chewable™, the Newest Addition to the Prenate® Prenatal Vitamin Family
5/21/2013
More...
|
Anthrax Drug Brings $334 Million to Pentagon Advisor's Biotech Firm - Human Genome Sciences, Inc. (HGSI)
5/20/2013
More...
|
Immune Response BioPharma Sets Pricing of REMUNE Vaccine in Thailand Between $75 -100 Per Dose
5/20/2013
More...
|
Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color
5/17/2013
More...
|
XenoPort, Inc. (XNPT) Provides Update on Availability of Horizant
5/17/2013
More...
|
IMPAX Laboratories, Inc. (IPXL) Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegrating Tablets in the U.S.
5/17/2013
More...
|
Mylan Inc. (MYL) Launches Generic Tricor® Tablets
5/17/2013
More...
|
Mylan Inc. (MYL) Launches Generic Zomig® Tablets
5/15/2013
More...
|
EMD Millipore Launches OsteoMAX-XF™, a Fully-Defined, Xeno-Free Mesenchymal Stem Cell Osteogenic Differentiation Medium
5/9/2013
More...
|
GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck & Co., Inc. (MRK)’s HPV Vaccine, Available to Developing Countries through UNICEF Tender
5/9/2013
More...
|
Merck & Co., Inc. (MRK), GlaxoSmithKline (GSK) Reduce HPV Vaccine Prices by 95 Pct. in Poorest Regions
5/9/2013
More...
|
Non Profit to Bayer AG (BAY.F): Withdraw False Vitamin Claims or Else!
5/9/2013
More...
|
pSivida Corp (PSDV) Announces Commercial Launch of ILUVIEN® in Germany With First Patient Treated
5/8/2013
More...
|
Kraig Biocraft Laboratories, Inc. Announces Plans to Launch Initial Commercial Production of Monster Silk™
5/7/2013
More...
|
Pfizer Inc. (PFE) Goes Online With Viagra, Is This a Good Idea?
5/7/2013
More...
|
BioTie Therapies Corp.: Selincro Launched in the United Kingdom
5/6/2013
More...
|
BioTie Therapies Corp.: Selincro Launched in the United Kingdom
5/6/2013
More...
|
Valeant Pharmaceuticals International (VRX) Provides Efinconazole Update
5/3/2013
More...
|
Martindale Pharma® Launches Prenoxad® Injection for the Emergency Treatment of Opioid Overdose
5/3/2013
More...
|
Retractions?! Conflicts?! Novartis AG (NVS) Probes Diovan Research
5/3/2013
More...
|
ThromboGenics Ltd. (THR.BR)' JETREA® Available in Germany Public and Private Market
5/2/2013
More...
|
Martindale Pharma® Launches Tapclob®, the First Licensed Oral Liquid Suspension of Clobazam
5/1/2013
More...
|
Sigma-Tau Pharmaceuticals Launches CYSTARAN™ for the Treatment of Corneal Cystine Crystal Accumulation in Patients With Cystinosis
5/1/2013
More...
|
Navidea Biopharmaceuticals (NAVB) Announces the U.S. Launch of Lymphoseek®
5/1/2013
More...
|
Putney, Inc. Launches Generic of Baytril® Taste Tabs®
4/30/2013
More...
|
EMD Millipore Launches OsteoMAX-XF™, a Fully Defined, Xeno-free Mesenchymal Stem Cell Osteogenic Differentiation Medium
4/30/2013
More...
|
Alimera Sciences (ALIM) Announces Iluvien® Now Available in U.K.
4/29/2013
More...
|
Now Commercially Available, CHATEAL® Creates a Stir in the Market; Public Health Providers Benefit From Low Pricing, Stable Supply From Afaxys Pharmaceuticals
4/24/2013
More...
|
Nuvo Research Inc. (NRI.TO) Announces European Launch of Pliaglis® by Galderma Pharma S.A.
4/23/2013
More...
|
Kantar Health Data Show Zytiga is Most Used First-Line Treatment in Prostate Cancer
4/23/2013
More...
|
BioTie Therapies Corp.: Selincro Launched in First European Markets
4/22/2013
More...
|
Cipla Ltd. Launches Shanghai CP Guojian's Biosimilar in India
4/19/2013
More...
|
FDA Bans Generic Version of Purdue Pharma L.P.'s OxyContin
4/18/2013
More...
|
GlaxoSmithKline (GSK)'s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment
4/18/2013
More...
|
FDA Approval of VIVUS, Inc. (VVUS)'s Qsymia Expands the Obesity Customer Base
4/17/2013
More...
|
European Medicines Agency Staff Push to Restrict Servier Osteoporosis Drug
4/15/2013
More...
|
Lupin Ltd. (LUPN.BO) Launches Its Oral Contraceptive Daysee™ Tablets in the US Market; Generic of Seasonique® Tablets
4/12/2013
More...
|
Aptalis Pharmaceutical Technologies Launches PYLERA® in France: A Therapeutic Alternative for Eradicating Helicobacter Pylori and Preventing Relapse of H. Pylori Associated Peptic Ulcers
4/11/2013
More...
|
ThromboGenics Ltd. (THR.BR)' JETREA®, the First and Only Medicine for Treating Vitreomacular Traction, Now Launched in the UK
4/11/2013
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Withdraws Muscle Relaxant From the U.S.
4/11/2013
More...
|
GW Pharmaceuticals' Cannabinoid-Medicine Sativex® Moved to Schedule 4 of UK Drugs Act
4/10/2013
More...
|
Rafarma Pharmaceuticals Registers CEFTRIAXONE Under International Label
4/8/2013
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Exec Explains $55,000 Annual Cost of New Drug
4/5/2013
More...
|
Novartis AG (NVS) Blockbuster Linked to Retracted Papers
4/2/2013
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Prices New MS Pill Below Rival Meds
4/2/2013
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Zenatane™ (Isotretinoin Capsules USP)
3/29/2013
More...
|
Mission Pharmacal Company Introduces Prednisolone Sodium Phosphate Oral Solution 25mg/5mL
3/28/2013
More...
|
Pharming Group (PHGUF.PK) Announces European Medicines Agency Approval of New Manufacturing Site for Ruconest®
3/28/2013
More...
|
National Institute for Clinical Excellence (NICE) Issues Draft "No" for Pfizer Inc. (PFE)'s Xalkori, but Opens Consultation
3/28/2013
More...
|
Pfizer Inc. (PFE)'s Drug to Treat Tuberculosis in Short Supply
3/27/2013
More...
|
FDA Perspective Published in The New England Journal of Medicine Reinforces Safety of Boehringer Ingelheim Corporation's Pradaxa® (dabigatran etexilate)
3/26/2013
More...
|
Mallinckrodt Inc. Launches Additional Dosage Strengths of Generic CONCERTA® in U.S.
3/25/2013
More...
|
BASF Increases Prices for N,N-Dimethylformamide
3/25/2013
More...
|
FDA Denies Approval for GlaxoSmithKline (GSK) Bird Flu Vaccine
3/25/2013
More...
|
GW Pharmaceuticals, Almirall May Pull Cannabis Drug in German Price Row
3/20/2013
More...
|
Savient Pharmaceuticals, Inc. (SVNT) Drug Sales Drop
3/20/2013
More...
|
Mylan Inc. (MYL) Launches Generic Version of Xopenex® Inhalation Solution
3/18/2013
More...
|
Fertility Nutraceuticals, LLC Announces Release of ANDROENERGEN® CoQ10, New Male Fertility Supplement
3/13/2013
More...
|
Sanofi (France) (SAN.PA): U.S. Probes Disclosures to FDA About Patient Response to Plavix
3/11/2013
More...
|
Nuvo Research Inc. (NRI.TO) Announces U.S. Launch of Pliaglis® by Galderma
3/11/2013
More...
|
INNOPHARMA Announces Launch of Generic Cidofovir Injection in the United States
3/8/2013
More...
|
MBL International Introduces TransFix™ a Cellular Stabilization Agent
3/1/2013
More...
|
Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK) Diabetes Drugs Linked to Pancreatitis Risk
2/28/2013
More...
|
Galderma Canada Inc. Release: First of Its Kind Rosacea Therapy Now Available in Canada
2/27/2013
More...
|
VIVUS, Inc. (VVUS) Loss Grows to $57 Million Due to Weight Loss Drug Sales Costs
2/27/2013
More...
|
Avion Pharmaceuticals Announces the Launch of FeRiva™
2/26/2013
More...
|
Mylan Inc. (MYL) Launches Generic Antara® Capsules
2/25/2013
More...
|
Scimera BioScience Release: New Probiotic Targets 40 Million Sufferers of Antibiotic-Associated Diarrhea
2/22/2013
More...
|
CSL Behring Announces New Vial Size of Privigen® for Treatment of Primary Immunodeficiency and Chronic Immune Thrombocytopenic Purpura
2/22/2013
More...
|
Pricey Aegerion Pharmaceuticals, Inc. (AEGR) Cholesterol Pill Worries Insurers
2/22/2013
More...
|
Novartis AG (NVS), Roche (RHHBY) Accused by Italy of Eye Drug "Cartel"
2/22/2013
More...
|
R-Tech Ueno: Announcement of Commercial Availability of RESCULA® Eye Drops in the U.S. Market
2/21/2013
More...
|
Breckenridge Pharmaceutical, Inc. Announces Approval for Pioglitazone Hydrochloride Tablets
2/14/2013
More...
|
Santarus Inc. (SNTS) Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
2/14/2013
More...
|
SPI Pharma, Inc. Announces Actimask® Ibuprofen Taste-Masked Active
2/14/2013
More...
|
Novartis AG (NVS)'s Jakavi Turned Down by National Institute for Clinical Excellence (NICE) for Blood Cancer
2/13/2013
More...
|
VIVUS, Inc. (VVUS): Slow and Steady Can Win the Diet Drug Race
2/12/2013
More...
|
Putney, Inc. Launches First FDA Approved Veterinary Generic of Simplicef®
2/11/2013
More...
|
Ipsen (IPN.PA) Release: Eziclen® / Izinova® a New Product for Bowel Cleansing Successfully Completed European Decentralised Registration Procedure
2/7/2013
More...
|
Verenium Corporation (VRNM) Announces Commercial Launch of Pyrolase® HT Product
2/4/2013
More...
|
Biotest Pharmaceuticals Announces First Commercial Sales of BIVIGAM™
2/4/2013
More...
|
Supernus Pharmaceuticals (SUPN) Launches Oxtellar XR™ in the United States
2/1/2013
More...
|
Perrigo Company (PRGO) Commences Launch of Clobetasol Emulsion Propionate Foam, 0.05%
2/1/2013
More...
|
Luqa Pharmaceuticals Launches Strataderm® in China
2/1/2013
More...
|
Vertex Pharmaceuticals (MA) (VRTX) Release: Republic of Ireland Approves Funding for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis, for People With a Specific Genetic Mutation (G551D)
2/1/2013
More...
|
UK's National Institute for Clinical Excellence (NICE) Rejects Genentech (RHHBY)'s Avastin for Ovarian Cancer
2/1/2013
More...
|
European Commission (EC) Charges Johnson & Johnson (JNJ) and Novartis AG (NVS) With Pay-to-Delay
1/31/2013
More...
|
Charles Hensley, Ph.D., Inventor of Zicam® Cold Remedy, and Itonis Pharmaceuticals, Readying Manufacturer for Anti-Nausea Nasal Spray
1/30/2013
More...
|
BIONOVA introduces a New Generation of the Neck Cream
1/29/2013
More...
|
GlaxoSmithKline (GSK) Vaccine Linked to 800 Children Narcolepsy Cases in EU
1/28/2013
More...
|
Sanofi (France) (SAN.PA) Announces Auvi-Q™, the First and Only Voice-Guided Epinephrine Auto-Injector, is Now Available in the U.S.
1/28/2013
More...
|
Bioniche Life Sciences Inc. (BNC) Launches Two New Animal Health Products in Canada
1/25/2013
More...
|
Sanofi Canada Release: Allerject™ Canada's First "Talking" Epinephrine Auto-Injector
1/25/2013
More...
|
AGNSS Recommends Alexion Pharmaceuticals Inc. (ALXN)'s Soliris® (eculizumab) for aHUS and Concludes "Eculizumab Would Help Save Lives and Improve the Quality of Life for Children and Adults With Atypical Haemolytic Uraemic Syndrome"
1/24/2013
More...
|
Amarin Corporation PLC (AMRN) Announces Market Introduction of Vascepa® (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG)
1/24/2013
More...
|
Exelixis, Inc. (EXEL) Announces COMETRIQ™ (cabozantinib) Is Now Available in the U.S.
1/24/2013
More...
|
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE) Drug Wins National Institute for Clinical Excellence (NICE) Nod for Irregular Heartbeats
1/23/2013
More...
|
Teijin Pharma to Launch Ipsen (IPN.PA)'s Somatuline® Subcutaneous Injection in the Treatment of Acromegaly and Pituitary Gigantism in Japan
1/17/2013
More...
|
Medical Marijuana, Inc. and Portfolio Company Red Dice Holdings Launches Re-Brand of Innovative Hemp Oil Wellness Product Line
1/17/2013
More...
|
Pfizer Inc. (PFE)'s Prevnar Vaccine is Effective, So Why Do Some Hate It?
1/17/2013
More...
|
Perrigo Company (PRGO) Announces Commercial Launch of Betamethasone Valerate Foam 0.12%
1/16/2013
More...
|
Abattis Receives US and Taiwan Trademark Approvals for Anti-viral Brand Defenzall™
1/16/2013
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. 's Generic Drug Nalmefene Hydrochloride Receives Approval for Pharmaceutical Registration From State FDA
1/16/2013
More...
|
Pfizer Inc. (PFE) Announces Availability of Quillivant XR™ (methylphenidate hydrochloride) CII For Extended-Release Oral Suspension in the United States
1/14/2013
More...
|
ULURU Inc. Announces the Launch of Altrazeal® 0.75 Gram Blister Pack in the United States
1/14/2013
More...
|
India Takes Another Swipe at Big Pharmas Such as Bristol-Myers Squibb Company (BMY), Roche (RHHBY); Govt. to Make 3 Key CA Drugs Cheaper
1/14/2013
More...
|
Sagent Pharmaceuticals, Inc. Announces the Temporary Importation of Sodium Bicarbonate Injection, USP
1/10/2013
More...
|
Journal Refuses to Retract GlaxoSmithKline (GSK)'s Controversial Paxil Study
1/10/2013
More...
|
ULURU Inc. Announces Shipment of Altrazeal® for First European Launch
1/8/2013
More...
|
Fresenius Kabi USA Launches Treatment for Acetaminophen Overdose
1/8/2013
More...
|
Wockhardt Launches Generic Version of Anti-Convulsant Drug Lamictal XR®
1/8/2013
More...
|
BioAlliance Pharma Announces the Launch of Oravig® in the United States by Its New Partner, Vestiq Pharmaceuticals
1/7/2013
More...
|
Perrigo Company (PRGO) Announces Launch of Authorized Generic Version of Acetadote® (Acetylcysteine) Injection
1/7/2013
More...
|
Prasco Laboratories Launches Authorized Generic of Lysteda® (tranexamic acid) Tablets
1/7/2013
More...
|
IMPAX Laboratories, Inc. (IPXL) Launches Oxymorphone Hydrochloride Extended-Release Tablets
1/4/2013
More...
|
How Much? Payers and the New Pfizer Inc. (PFE) RA Pill
1/4/2013
More...
|
Sagent Pharmaceuticals, Inc. Announces the Launch of Flumazenil Injection, USP
1/3/2013
More...
|
Discovery Laboratories (DSCO) Initiates Launch of AFECTAIR®
1/3/2013
More...
|
Affymax, Inc. (AFFY) and Takeda Pharmaceuticals Announce Permanent J-Code for OMONTYS® (peginesatide) Injection is in Effect
1/3/2013
More...
|
Teva Respiratory Release: ProAir® HFA (Albuterol Sulfate) With Dose Counter Now Available to Patients
1/3/2013
More...
|
Mallinckrodt Inc. Launches Generic Version of CONCERTA® in U.S.
1/2/2013
More...
|
Mylan Inc. (MYL) Launches First Generic Maxalt MLT® Tablets
1/2/2013
More...
|
Mylan Inc. (MYL) Launches Generic Nordette® 28 Tablets
12/28/2012
More...
|
Mylan Inc. (MYL) Launches Generic Dilantin® Chewable Tablets
12/28/2012
More...
|
VIVUS, Inc. (VVUS) Diet Pill to be Covered by Express Scripts Inc.
12/21/2012
More...
|
FDA Denies Merck & Co., Inc. (MRK) Request to Block Generic Form of Nasonex
12/20/2012
More...
|
Vertex Pharmaceuticals (MA) (VRTX) Release: National Health Service in England Funds KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis, for People With a Specific Genetic Mutation (G551D)
12/19/2012
More...
|
AstraZeneca PLC (AZN) Release: BRILINTA (Ticagrelor) Receives Additional Class I Recommendation in Updated ACCF/AHA Guidelines for the Management of STEMI Patients
12/18/2012
More...
|
Mylan Inc. (MYL) Launches Generic Version of Qualaquin® Capsules
12/18/2012
More...
|
Ironwood Pharmaceuticals and Forest Laboratories, Inc. (FRX) Announce U.S. Availability of LINZESS™ (Linaclotide)
12/17/2012
More...
|
Aptalis Pharmaceutical Technologies Announces European Commission Approval for a New Oral Granule Formulation of Viread®
12/13/2012
More...
|
Endo Health Solutions Inc. (Formerly Known as Endo Pharmaceuticals Holdings Inc.) (ENDP) Launches 7.5mg and 15mg Strengths of Reformulated, Designed to be Crush-Resistant, OPANA® ER
12/12/2012
More...
|
Forest Laboratories, Inc. (FRX) and Almirall Announce Commercial Availability of Tudorza™ Pressair™ in U.S. Pharmacies
12/11/2012
More...
|
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, Launches First Generic Version of Grifulvin V®
12/11/2012
More...
|
Acura Pharmaceuticals, Inc. (ACUR) Launches Next Generation Cold Medicine to Aid in the Fight Against Meth
12/10/2012
More...
|
Aptalis Pharmaceutical Technologies Announces U.S. Commercial Availability of ULTRESA™ (Pancrelipase) Delayed-Release Capsules
12/10/2012
More...
|
GeneTex, Inc. Launches New Antibody Against Phosphorylated Histone H3 for Epigenetics Research
12/10/2012
More...
|
Genzyme Corporation (GENZ) Receives European Label Expansion for Thyrogen
12/7/2012
More...
|
Catalent Pharma Solutions to Supply the Newly Approved Exelixis Cometriq™ (Cabozantinib) in the U.S. Market
12/7/2012
More...
|
National Institute for Clinical Excellence (NICE) Says "No" on Pfizer Inc. (PFE) Kidney Cancer Drug
12/7/2012
More...
|
Bioniche Life Sciences Inc. (BNC) Launches NexHA™ in Canada
12/5/2012
More...
|
Mylan Inc. (MYL) Launches Generic Version of Atacand HCT®
12/5/2012
More...
|
Tanzania Expands Immunization Program to Include Pfizer Inc. (PFE)'s Prevenar 13 for Prevention of Pneumococcal Disease
12/5/2012
More...
|
curasan AG (DX:CUR) Now Sells Bone Regeneration Material in Injectable Form
12/5/2012
More...
|
MYOS (MYOS) Announces MYO-X Now Available in GNC; Vitamin Shoppe Soon to Follow
12/4/2012
More...
|
Horizon Pharma, Inc. (HZNP) Begins Initial Commercial Launch of RAYOS® (prednisone) Delayed-Release Tablets in the United States
12/3/2012
More...
|
Mylan Inc. (MYL) Launches Generic Detrol® Tablets
11/29/2012
More...
|
Fat Chance: The VIVUS, Inc. (VVUS) Diet Pill Has Skinny Sales
11/28/2012
More...
|
Pfizer Inc. (PFE) Destroyed Celebrex Files, Investors Claim
11/27/2012
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Launches Absorica™ (Isotretinoin) Capsules in the U.S. Healthcare Market
11/26/2012
More...
|
Sucampo Pharmaceuticals, Inc. and Abbott Laboratories (ABT) Announce Launch of AMITIZA in Japan
11/26/2012
More...
|
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA) Shares Jump on Insurance Coverage for Fat Pills
11/23/2012
More...
|
Supernus Pharmaceuticals (SUPN) Receives Three Years of Market Exclusivity for Oxtellar XR™
11/19/2012
More...
|
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, to Launch First Generic Version of Gris-PEG®
11/19/2012
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of SILDENAFIL TABLETS
11/19/2012
More...
|
Vertex Pharmaceuticals Incorporated (VRTX) Release: INCIVEK™ (telaprevir) Now Funded in Alberta and New Brunswick for People With Hepatitis C
11/15/2012
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces First Shipment of Generic Phendimetrazine Tablet Product
11/15/2012
More...
|
Bayer AG (BAY.F) Bets $4 Billion on R8D and Sales From 5 Blockbuster Drugs
11/14/2012
More...
|
Roche (RHHBY) Fails to Address Question of Missing Tamiflu Data
11/14/2012
More...
|
Endo Health Solutions Inc. (Formerly Known as Endo Pharmaceuticals Holdings Inc.) (ENDP) Supplements Citizen Petition With Preliminary Data Showing a 59% Drop in Abuse of the Reformulated, Designed to be Crush-Resistant, OPANA® ER
11/14/2012
More...
|
Sagent Pharmaceuticals, Inc. Announces the Launch of Acetazolamide for Injection, USP
11/13/2012
More...
|
Genzyme Corporation (GENZ) Announces Return to Full Supply of Thyrogen (thyrotropin alfa for injection)
11/13/2012
More...
|
Mylan Laboratories Inc. (MYL) Launches Generic Version of Revatio® Tablets
11/13/2012
More...
|
Sanofi (France) (SAN.PA) Halves Price of Cancer Drug After Rejection From Cancer Center
11/9/2012
More...
|
National Institute for Clinical Excellence (NICE) Rejects Novartis AG (NVS) Asthma Drug in Change of Tack
11/9/2012
More...
|
Cipla Ltd. Slashes Cancer Drug Prices by Up to 64 Pct
11/8/2012
More...
|
AstraZeneca PLC (AZN), PTSD and a Buried Seroquel Study
11/8/2012
More...
|
FDA Rejects Petition to Ban Pfizer Inc. (PFE) Alzheimer Pill
11/8/2012
More...
|
Merck & Co., Inc. (MRK) May Not Have Shown Women Can Safely Choose Drug
11/8/2012
More...
|
Bristol-Myers Squibb Company (BMY) Receives Positive Decision From National Institute for Clinical Excellence (NICE) for YERVOY® (ipilimumab)
11/2/2012
More...
|
British Medical Journal Pushes Roche (RHHBY) for Raw Data on Tamiflu Trials
10/31/2012
More...
|
Sagent Pharmaceuticals, Inc. Announces the Launch of Leucovorin Calcium for Injection
10/29/2012
More...
|
Phagenesis Ltd Launches First Treatment for Acute Dysphagia
10/25/2012
More...
|
Discovery Laboratories (DSCO) Provides Commercial Update for SURFAXIN® and AFECTAIR®
10/24/2012
More...
|
GeneTex Antibody Company to Launch a New Primary Antibody for the Detection of Oxidized CaMKII
10/23/2012
More...
|
NicOx SA (COX.PA) Launches AdenoPlus™ in the United States
10/22/2012
More...
|
DARA BioSciences, Inc. Launches Soltamox®, First and Only Liquid Version of Tamoxifen Citrate
10/22/2012
More...
|
P.L. Thomas and HG&H Pharmaceuticals Slated for Full-Scale, Broad Market Launch of Clinically Supported Zembrin® Sceletium Tortuosum at Supply Side West 2012
10/22/2012
More...
|
Quadex Labs Launches Revolutionary Professional-Grade Cold Sore Treatment
10/19/2012
More...
|
Bristol-Myers Squibb Company (BMY) Release: FDA Approves Labeling Update for BARACLUDE® (entecavir) (0.5 mg/1 mg Tablets) to Include Data on African Americans and Liver Transplant Recipients With Chronic Hepatitis B in Adult Patients
10/16/2012
More...
|
Novartis AG (NVS) Drug Diovan Retains 69% of Prescriptions in U.S.
10/16/2012
More...
|
National Institute for Clinical Excellence (NICE) Stroke Guidance Boost for Boehringer Ingelheim Corporation's Actilyse
10/16/2012
More...
|
Sigma-Tau Pharmaceuticals Announces the U.S. Launch of VSL#3® JUNIOR
10/16/2012
More...
|
Johnson & Johnson (JNJ) to Restore Full Access to Doxil Cancer Drug
10/16/2012
More...
|
AHF Advocacy Against Gilead Sciences, Inc. (GILD)'s Truvada as HIV Prevention Yields Stronger FDA Drug Warning Label
10/12/2012
More...
|
Tarsa Therapeutics to Assist Therapicon in Its Challenge to CHMP's Recommendation to Limit Use of Calcitonin
10/12/2012
More...
|
Sigma-Tau Pharmaceuticals Offers New Co-Pay Assistance Program for Adagen® Patients
10/9/2012
More...
|
IntelGenx Corp. Announces Commercial Launch of Forfivo XL™ in USA
10/9/2012
More...
|
Ranbaxy Pharmaceuticals Inc. Launches Authorized Generic of Evoxac in the U.S. Healthcare Market
10/9/2012
More...
|
Edgemont Pharmaceuticals, LLC. Release: New Higher Dose Bupropion Extended-Release Tablets Now Available
10/9/2012
More...
|
VIVUS, Inc. (VVUS) Release: Express Scripts Inc. Joins Qsymia™ (Phentermine and Topiramate Extended-Release) Certified Home Delivery Pharmacy Network
10/8/2012
More...
|
Accidental Blockbusters - Pfizer Inc. (PFE)'s Viagra Made It Big Through Serendipity, Will Other Drugs?
10/8/2012
More...
|
National Institute for Clinical Excellence (NICE) U-turns on Novartis AG (NVS)'s Lucentis for Diabetic Macular Oedema
10/5/2012
More...
|
Zenmark Names Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s REVESTIVE (teduglutide): a New Drug for the Treatment of Short Bowel Syndrome
10/4/2012
More...
|
ChiRhoClin Release: ChiRhoStim® (Human Secretin for Injection) is Now Commercially Available
10/4/2012
More...
|
Sagent Pharmaceuticals, Inc. Announces the Launch of Caffeine Citrate Injection, USP and Caffeine Citrate Oral Solution, USP
10/3/2012
More...
|
Roche (RHHBY)'s New Dual-Target HIV-1 Viral Load Test Now Available in U.S.
10/3/2012
More...
|